同步双边乳腺癌与不一致的受体状态:治疗一个病人,但两个疾病

相关实验视频

Updated: Jul 26, 2025

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

2.7K

Ademola S Ojo1, Adedoyin Shittu1, Stacy Amadife1

  • 1Department of Internal Medicine, Howard University Hospital, Washington, DC, USA.

World journal of oncology
|June 23, 2023
PubMed
概括

当受体状态不同时,同步双边乳腺癌会带来治疗挑战. 这一案例突出了管理三阴性瘤与HER2阳性瘤一起.

关键词:
乳腺癌 乳腺癌 乳腺癌雌激素受体的受体是什么人类表皮生长因子受体孕激素受体是什么? 孕激素受体是什么?

更多相关视频

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.1K
High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts06:06

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts

Published on: December 20, 2024

639

相关概念视频

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K